Brigham and Women’s Hospital researchers recently conducted the first study of patient-reported data on the economic burden of neuromyelitis optica spectrum disorders (NMOSD). Specifically, they characterized the direct and indirect costs of relapse events (ED visits and hospitalizations).

Researchers at Brigham and Women’s Hospital have designed two promising AAV9 variants that are much more effective than the parent vector for delivering therapeutic transgenes into the central nervous system of mice and macaques.

Researchers at Brigham and Women’s Hospital have shown more specifically that humans have a spatial massive memory—they can remember where they saw objects presented briefly—and a temporal massive memory—they can remember when they saw the objects.

Researchers at Brigham and Women’s Hospital recently reported that somatic variants—specifically, in the supervillin (SVIL) gene—increase susceptibility to intracranial aneurysms through changes in vascular smooth muscle cells (vSMCs).

On April 22–27, 2023, the American Academy of Neurology hosts its 75th annual meeting in Boston, MA and virtually. Leaders from the Department of Neurology at Brigham and Women’s Hospital will present their latest research at the meeting alongside international colleagues.

Experts from the Department of Neurosurgery at Brigham and Women’s Hospital join other neurosurgical leaders at this year’s AANS Annual Scientific Meeting, “Neurosurgeons as Advocates,” held April 21 – 24, 2023, in Los Angeles, CA.

Herpes simplex virus (HSV) is the most common cause of viral encephalitis. The brain lesions in HSV encephalitis (HSVE) primarily involve the temporal and frontal lobes. About half of patients develop seizures, which may progress to chronic seizure disorders or status epilepticus.